Research could treat Type I Diabetes by engineering pancreatic islets outside the body

August 23, 2017 by Matt Cichowicz, University of Pittsburgh
Dr. Banerjee (right) with PhD Candidate Thomas Richardson. Credit: Swanson School of Engineering/Paul Kovach

Tiny packets of cells called islets throughout the pancreas allow the organ to produce insulin. Type 1 diabetes—also known as juvenile diabetes - tricks the immune system into destroying these islets. Patients must take insulin daily to maintain blood sugar, or too much sugar will build up in the blood stream and lead to hyperglycemia, diabetic ketoacidosis, and, if left untreated, death. Patients must self-regulate their blood sugar for their entire lives, unless there were some way to restore the pancreatic islets.

To explore that potential, the National Science Foundation has funded a multi-university study led by researchers at the University of Pittsburgh Swanson School of Engineering who are investigating the use of human (hPSCs) to engineer in the lab. A major goal of the research is to develop a method of vascularizing islets in vitro—literally "in glass"—which studies suggest will result in higher viability and enhanced function after the transplant.

"This the first attempt to generate in vitro vascularized pancreatic islet organoids from hPSCs," explains Ipsita Banerjee, associate professor of chemical engineering at Pitt and principal investigator of the study. "Through collaborative efforts, we have developed a method of implanting blood vessel fragments into the islets. By vascularizing the islets before they are transplanted to the body, they are more likely to survive and can begin regulating blood glucose more quickly."

Pancreatic islets have a very high oxygen demand. Once inside the body, they need to connect to the host vessels quickly, otherwise they start dying and lose their ability to regulate levels. Researchers began looking for new techniques to speed up vascularization after tests began to show high vascularity ultimately improved the transplantation outcome.

In addition to developing vascularized islets inside the lab, the study—"Engineering a functional 3D vascularized islet organoid from pluripotent stem "—will use a novel hydrogel system to create a three-dimensional cell culture configuration that mimics the way the body forms pancreatic cells naturally.

"The hydrogel is like a scaffold, and it helps to configure the cells in a 3D space," says Dr. Banerjee. "The status quo is hPSCs randomly arranged in uncontrolled configurations with varying size and structure; however, by using the hydrogel developed by our collaborator at Arizona State, we can create a precise, multicellular architecture called 'spheroids.' Unlike a 2D culture grown in a petri dish, islet spheroids grown on the hydrogel look the same as the ones made by the body."

Although Dr. Banerjee's research will most directly impact cell therapy for diabetics, creating a procedure for developing working islets outside of the body could also serve as a valuable tool for testing the efficacy and toxicity of new drug compounds for pancreatic disease. The general implications of in vitro vascularization of cells show even more promise.

"The principles behind pre-designing vascularization before transplantation apply to any type of tissue, not just pancreatic," Dr. Banerjee says. "Even when donor islets are used for a transplant, a fraction of the islets survive the procedure. We expect the advanced measures we are taking in the lab, before the new cells enter the patient's body, to have tremendous application to the next generation of regenerative medicine."

Explore further: The best place to treat type 1 diabetes might be just under your skin

Related Stories

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New transplant technology could benefit patients with type 1 diabetes

June 5, 2017
Combining a new hydrogel material with a protein that boosts blood vessel growth could improve the success rate for transplanting insulin-producing islet cells into persons with type 1 diabetes. In an animal model, the technique ...

New procedure could improve success rate of cell transplant to cure type 1 diabetes

April 4, 2016
New research suggests pretreating cells with a peptide hormone may improve the success rate of pancreatic islet cell transplants, a procedure that holds great promise for curing Type 1 diabetes. The results will be presented ...

A pharmacological approach to improving pancreatic beta cell growth and function

March 17, 2016
β cells in pancreatic islets are responsible for producing insulin, which is essential to regulate blood glucose homeostasis. In type 1 diabetes, pancreatic β cells are destroyed due to an autoimmune attack, whereas in ...

Engineered pancreatic tissues could lead to better transplants for diabetics

August 15, 2012
Technion researchers have built pancreatic tissue with insulin-secreting cells, surrounded by a three-dimensional network of blood vessels. The engineered tissue could pave the way for improved tissue transplants to treat ...

Novel tissue-engineered islet transplant achieves insulin independence in type 1 diabetes

May 11, 2017
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered ...

Recommended for you

Kidney cells engineered to produce insulin when caffeine is present in the body

June 22, 2018
A team of researchers from ETH Zurich and the University of Basel in Switzerland and Institut Universitaire de Technologie in France has that found that embryonic kidney cells engineered to produce insulin when exposed to ...

Diagnosing diabetes from a single blood sample

June 18, 2018
Diagnosing type 2 diabetes in clinical practice may require only a single blood sample, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Lentils significantly reduce blood glucose levels, study reveals

June 13, 2018
Replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 per cent, according to a first-ever University of Guelph study.

Is there a link between diabetes and Parkinson's disease?

June 13, 2018
People with type 2 diabetes may have an increased risk of having a diagnosis of Parkinson's disease later in life, according to a large study published in the June 13, 2018, online issue of Neurology, the medical journal ...

Double-checking diabetes medications may reduce re-hospitalizations

June 11, 2018
Clinicians may take upwards of 15 minutes to double-check a patient's medication list in an electronic health record system, but according to a new study, this reconciliation process may be well worth the time for diabetes ...

How a gene linked to obesity could provide new insights into diabetes

June 8, 2018
A gene previously linked with obesity has been found to affect how the body processes insulin, with potential implications for some forms of diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.